To explore its role in epithelial disruption in eosinophilic esophagitis (EoE), recent studies have demonstrated that targeting FOXM1 restores epithelial homeostasis, reduces immune-mediated activity, and represents a potential novel treatment strategy for EoE [91]. The gene discussed is FOXM1; the disease is eosinophilic esophagitis.